Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Main Authors: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2020-12-01
|
丛编: | Vaccines |
主题: | |
在线阅读: | https://www.mdpi.com/2076-393X/9/1/3 |
相似书籍
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
由: Robin John Shattock, et al.
出版: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
由: Wenshuo Zhou, et al.
出版: (2023-08-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
由: Bruna Aparecida Souza Machado, et al.
出版: (2021-11-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
由: Dylan Kairuz, et al.
出版: (2022-10-01) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
由: Yoann Aldon, et al.
出版: (2021-09-01)